YAP1 and cancer: Dysregulation of this pathway has been shown to lead to aberrant stabilization and activation of YAP1/TAZ protein, resulting in tumorigenesis, progression, metastasis, and recurrence [18, 19], and further causing drug resistance by acquisition of cancer stem cell-like properties [20–24].